Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Glaucoma: Overview01:25

Glaucoma: Overview

1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

8.8K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.8K
Anatomy of the Eyeball01:20

Anatomy of the Eyeball

9.4K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
9.4K
Prosopagnosia01:24

Prosopagnosia

702
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
702

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Surgery on the edge: shaping the future between motivation, burnout, and gender inequities-a narrative review.

Updates in surgery·2026
Same author

The Eye and the Brain: Photonic Devices in Neuro-Ophthalmology.

Diseases (Basel, Switzerland)·2026
Same author

Special Issue "Integrated Approaches, Molecular Mechanisms and Therapies in Ocular Surface Diseases".

International journal of molecular sciences·2026
Same author

Immune-Metabolic Interactions in the Degenerative Retina: A Systems Biology Approach Based on Diabetic Retinopathy.

Frontiers in bioscience (Landmark edition)·2026
Same author

Visual and Patient-Reported Outcomes After Bilateral Implantation of Two Enhanced Monofocal IOLs.

Journal of clinical medicine·2026
Same author

Four-dimensional ultrasound versus torsional ultrasound phacoemulsification in cataracta nigra: a single-nucleus <i>ex vivo</i> bench pilot.

Frontiers in ophthalmology·2026

相关实验视频

Updated: Jan 16, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.6K

超越眼睛:玻璃眼和大脑

Marco Zeppieri1,2, Federico Visalli3, Mutali Musa4,5

  • 1Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.

Brain sciences
|September 27, 2025
PubMed
概括
此摘要是机器生成的。

玻璃眼不仅仅涉及眼睛;它显示了类似于神经退行性疾病的大脑变化. 这表明,对于青光眼患者来说,针对中枢神经系统 (CNS) 的新疗法.

关键词:
中枢神经系统中枢神经系统玻璃眼 glaucoma 玻璃眼 玻璃眼 玻璃眼 玻璃眼神经退行症的神经退行症神经保护神经保护视网膜质细胞是视网膜质细胞

更多相关视频

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.5K
An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
09:46

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

Published on: July 15, 2025

1.4K

相关实验视频

Last Updated: Jan 16, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.6K
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.5K
An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
09:46

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

Published on: July 15, 2025

1.4K

科学领域:

  • 神经眼科神经眼科
  • 神经退行发生神经退行.
  • 中枢神经系统 (CNS) 研究研究

背景情况:

  • 玻璃眼传统上被视为一种眼部疾病,导致视网膜质细胞 (RGC) 损失.
  • 新出现的证据表明,青光瘤涉及跨突触神经退行和中枢大脑变化.

研究的目的:

  • 审查证据支持格劳科马被归类为中枢神经系统疾病.
  • 探索青光眼和神经退行性疾病之间的共享机制.
  • 讨论关于格洛科马大脑参与的临床影响.

主要方法:

  • 关于对绿眼病患者的神经成像和神经认知研究的叙述性综述.
  • 综合证据的中央神经系统 (CNS) 病理在眼.
  • 探索与阿尔茨海默氏症和帕金森病共享的病理生理机制.

主要成果:

  • 玻璃眼患者表现出大脑连接性改变和皮质稀薄.
  • 共同的机制包括线粒体功能障碍,炎症和轴突运输受损.
  • 玻璃眼与阿尔茨海默氏症和帕金森症等疾病共享神经退行性途径.

结论:

  • 玻璃眼的病理生理延伸到中枢神经系统 (CNS).
  • 针对中枢神经系统的神经保护和神经再生策略具有治疗潜力.
  • 神经成像生物标志物和针对大脑的干预措施可以促进青光眼的诊断和治疗.